Wegovy maker Novo Nordisk filed for U.S. FDA approval of CagriSema, a once-weekly shot that combines two compounds to treat ...
As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...
The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...
Doctors and groups representing employers said they’re increasingly hearing about companies cutting weight loss drugs out of ...
Scripps News on MSN
Eli Lilly seeks FDA approval for pill that maintains weight loss after Wegovy, Zepbound
Eli Lilly seeks FDA approval for orforglipron, a once-daily pill shown in trials to help maintain weight loss after stopping ...
The best weight loss medication for men includes semaglutide (Ozempic , Wegovy ), tirzepatide (Mounjaro , Zepbound ), and ...
Novo Nordisk said on Friday the European Medicines Agency's committee had issued a positive opinion for a higher dose of its ...
Eli Lilly reports Phase 3 data showing oral obesity drug orforglipron maintained weight loss after Wegovy or Zepbound, beating placebo.
Imagine this scenario: You’ve been diligently working toward your weight management goals, and your healthcare team has prescribed Wegovy (semaglutide). You’re excited, you’ve done your research, and ...
Have you ever searched for information about the side effects of a medication? These days, most people put the name of their drug into a search engine along with the phrase "side effects." Whatever ...
Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results